Immunologic Profile of Peritoneal Cancer
Immunologic, Cellular, and Anti-microbial Profiling of Intraperitoneal Chemotherapy
Sponsor: MercyOne Des Moines Medical Center
Listed as NCT03230240, this observational or N/A phase trial focuses on Carcinomatosis and remains ongoing. Sponsored by MercyOne Des Moines Medical Center, it has been updated 12 times since 2016, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Nov 2022 — Jul 2024 [monthly]
Unknown Status
Status: Active Not Recruiting → Unknown Status
-
Dec 2021 — Nov 2022 [monthly]
Active Not Recruiting
-
Jan 2021 — Dec 2021 [monthly]
Active Not Recruiting
▶ Show 7 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Active Not Recruiting
-
Oct 2020 — Nov 2020 [monthly]
Active Not Recruiting
Status: Unknown Status → Active Not Recruiting
-
Feb 2020 — Oct 2020 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jun 2018 — Feb 2020 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
Jan 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- MercyOne Des Moines Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .